Treeline Biosciences

Treeline BiosciencesTreeline was founded in 2021 with the aim of developing transformative precision medicines for cancer and other serious diseases. The company's platform involves the evaluation of normal and disease pathophysiology, experimental results, genomics, and pattern recognition to develop transformative precision solutions that address unmet patient needs, enabling healthcare professionals to cure cancer and other serious diseases.